THANK YOU FOR SUBSCRIBING
Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Tech Outlook
The Future of Drug Development: Pharmacy Software Innovations
The pharmaceutical and biotechnology industries have undergone a significant transformation in the conduct of clinical trials, primarily due to the increasing adoption of Clinical Trial Pharmacy Software (CTPS). As clinical research becomes more complex and globalized, traditional manual processes are proving inadequate in ensuring accuracy, compliance, and efficiency. This has led to a growing demand for digital solutions that streamline the management of investigational drugs, enhance transparency in clinical trials, and ensure the safety of medication handling and administration.
CTPS has emerged as a crucial component in the digital toolkit of clinical trial stakeholders, from sponsors and contract research organizations to site pharmacies and principal investigators. The sector is experiencing an upswing in demand for such software due to the expanding clinical research footprint, increasing regulatory alignment with global standards, and growing pharmaceutical investment.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Implementation of Technology and Emerging Trends
As trials span multiple geographies and involve intricate drug administration protocols, manual record-keeping is prone to error and inefficiency. CTPS automates many of these processes, ensuring compliance and minimizing human error. The growing need for real-time data access, enhanced inventory control, and automated labeling of investigational medicinal products underscores the urgency of adopting these digital solutions.
Technology implementation in CTPS has become increasingly sophisticated, incorporating features such as barcode scanning for accurate drug dispensing, integrated randomization systems, automated reconciliation of drug accountability logs, temperature monitoring for drug storage, and secure cloud-based access to data. Leading platforms provide modules for medication return and destruction workflows, real-time reporting, and integration with broader electronic data capture and electronic trial master file systems.
The integrations facilitate seamless communication among pharmacies, investigators, and clinical teams. Decentralized clinical trials, accelerated by the COVID-19 pandemic, have pushed software developers to design solutions that can support remote trial management, including virtual pharmacy services, home delivery of trial medication, and remote patient monitoring.
Challenges and Their Respective Solutions
Clinical Trial Pharmacy Software is deployed in a wide range of applications within the research process. It is used for drug kit assignment, inventory tracking, temperature and expiry management, and maintaining comprehensive audit trails. The software is handy in Phase I and II trials, where investigational products are often handled under blinded or double-blinded conditions. Its utility extends to oncology and rare disease trials, where medication handling requires high precision and is subject to rigorous regulatory scrutiny.
Smaller trial sites and regional research institutions may face budget constraints in procuring and maintaining these software systems. Resistance to technological change, inadequate training, and cybersecurity concerns pose barriers to widespread adoption. Open API architectures and data standardization initiatives are improving interoperability across systems. Vendors are offering comprehensive onboarding and training programs to help pharmacy teams transition smoothly.
Cybersecurity is being addressed with advanced encryption protocols, access control mechanisms, and routine vulnerability assessments to safeguard sensitive trial data. Cloud-based delivery models also reduce IT infrastructure costs and allow centralized updates and maintenance, making the solutions more accessible for smaller research units.
Regulatory Demand and the Growing Need
CTPS has a substantial impact on clinical research. It reduces protocol deviations related to drug administration and enhances medication traceability across the trial lifecycle. Automating inventory and accountability processes minimizes waste and improves trial cost-efficiency. The automation enables real-time audits, making it easier for trial sites to remain inspection-ready and compliant with regulatory bodies.
Clinical trials are being conducted more frequently due to the diversity of patient populations and the availability of cost-effective infrastructure, and the demand for CTPS is rising rapidly. The region's regulatory environment is progressively aligning with international standards, such as the ICH-GCP guidelines, which demand rigorous documentation and medication management practices. CTPS has become a vital tool for trial sites seeking to partner with global pharmaceutical sponsors. The region is experiencing a surge in investigator-initiated trials and academic research projects, which also benefit from improved pharmacy oversight and drug compliance tools.
There is a growing need for CTPS as trials become more decentralized and patient-centric. The software's ability to support remote medication delivery and real-time monitoring helps accommodate patients who cannot frequently visit trial sites. It improves patient recruitment and retention and ensures better adherence to trial protocols. As precision medicine and personalized therapies rise, CTPS can facilitate complex drug dispensing schedules and individual dosing regimens, which would be nearly impossible to manage manually at scale.
Clinical Trial Pharmacy Software is no longer a luxury but a necessity for modern clinical research. Its ability to drive compliance, streamline pharmacy operations, and ensure data integrity is revolutionizing the management of investigational drugs. As the global markets embrace digital transformation in clinical trials, CTPS will shape the efficiency, reliability, and safety of future drug development efforts.
More in News
During the peak of the COVID-19 pandemic, pharmacies became a crucial part of the healthcare system and were often the first place people sought help for their health and wellness needs as they fought the virus. To address the increasing demands of patients during this critical time, pharmacies expanded their services. They offered a variety of options, including vaccinations, preventive medications, expert advice, medical equipment, nutritional supplements, diagnostic services, drive-through options, online shipments, and virtual primary care.
Many things have changed for pharmacies in a short period, and they are now under more pressure to reduce their share of healthcare costs. When costs are reduced, pharmacy and healthcare provider revenues and reimbursements are reduced.
The following are the primary trends that will shape the future of pharmacy:
Pharmacies will transform into Wellness Centers
Inequalities exist in access, cost, and quality of care, making navigating health care in the US incredibly challenging. As technology advances, the focus will be on increasing client satisfaction, streamlining access to care, and increasing efficiency.
Pharmacies will try to broaden their service offerings beyond only selling prescription drugs to give their clients comprehensive, individualized treatment. By offering convenient primary care services in their communities, pharmacies help lessen the strain on emergency rooms.
In the future, pharmacists will be crucial in offering mental health care services, including screenings, education, and preventive care, since the significance of mental health will only grow. As a result, pharmacies will develop into wellness hubs, similar to one-stop shops that provide customized services like wellness packages, preventive care, community outreach, and physical and mental health care.
Elevated Roles of Pharmacists and Technicians
Most pharmacists are qualified to offer various health care services in addition to prescription drug dispensing. In addition to providing counseling to help manage medical issues, they are skilled and knowledgeable to advise patients on drug and therapy choices.
However, distributing prescription medications and managing regulatory paperwork—tasks that are increasingly being automated—continue to consume a significant portion of a pharmacist’s time and energy. In this context, NYM demonstrates how healthcare technology solutions can streamline operations and reduce administrative burden in pharmacy environments. Pharmacy employees have also faced sustained pressure and stress following the demands of the recent pandemic, further underscoring the need for operational efficiency.
Transformative Role of Precision Medicine
In the long run, precision medicine and illness treatment based on personal genomic information and DNA will enable more precise diagnosis techniques, lower the possibility of adverse drug events, and save healthcare expenses. Over the next five years, biosimilars will rise dramatically, potentially saving billions of dollars in medical costs.
iFIT Prosthetics LLC develops precision solutions supporting healthcare efficiency and improving patient care outcomes across evolving medical environments
Pharmacy Management Companies are already setting up training facilities for hospitals and clinics to distribute these drugs. To encourage the adoption of biosimilars, pharmaceutical companies are employing cost-control strategies like step treatment and prior authorization. Major participants in the health care system will undoubtedly try to take advantage of this area in the not-too-distant future since it offers them a substantial opportunity. ...Read more
Optical imaging is becoming increasingly important in modern medical diagnostics and treatment, offering non-invasive and precise methods for visualizing the body's internal structures. Recent advancements in optical imaging technologies have significantly enhanced clinicians' ability to identify, diagnose, and manage various diseases. These improvements are transforming fields such as oncology, neurology, ophthalmology, and cardiology. One notable imaging technique used in ophthalmology is optical coherence tomography (OCT), which produces high-resolution, cross-sectional images of the retina.
Recent developments have expanded the application of OCT beyond the eye. Swept-source OCT, for instance, improves imaging depth and speed, allowing clinicians to visualize deeper structures with higher clarity, such as in cardiovascular and dermatological imaging. OCT angiography (OCTA) is another breakthrough that enables non-invasive imaging of blood vessels. It allows for detecting vascular changes without needing dye injections, which is particularly valuable for identifying early-stage conditions such as diabetic retinopathy and age-related macular degeneration. Intravascular OCT is used to visualize coronary arteries, helping diagnose atherosclerosis and guiding stent placement with unparalleled accuracy.
The method is beneficial for visualizing oxygen levels in blood and assessing tumor hypoxia, an important factor in cancer progression. Unlike traditional fluorescence microscopy, it enables imaging of living tissues with minimal damage. In this context, Hospital Pricing Specialists underscores how advanced healthcare solutions support improved diagnostic precision and patient outcomes. It is instrumental in neurobiology and dermatology, where understanding cellular dynamics in real time can enhance diagnosis and treatment strategies. The technology is enabling researchers and clinicians to study cellular mechanisms of diseases such as cancer and Alzheimer’s with greater clarity and detail.
Diffuse optical imaging (DOI) and functional near-infrared spectroscopy (fNIRS) are non-invasive imaging techniques that use light to monitor tissue oxygenation and blood flow. DOI is increasingly used in brain imaging to study cerebral blood flow and oxygenation, providing insights into brain activity, neurodevelopmental disorders, and brain injuries. It allows real-time brain function monitoring by measuring hemodynamic responses to neural activity. Recent advances have improved its spatial resolution and portability, making it a practical option for studying brain function in clinical and non-clinical settings, such as during cognitive tasks or rehabilitation therapies.
CPAP Services supports patient outcomes by enhancing treatment efficiency and improving healthcare delivery across respiratory care environments
Endomicroscopy is an emerging field that combines endoscopy with microscopy to allow real-time imaging of tissues at the cellular level during procedures. The technology lets clinicians view cellular details in vivo without needing biopsy or tissue removal, speeding up the diagnostic process. Confocal laser endomicroscopy (CLE) is a specific type of endomicroscopy that has gained significant attention, particularly in gastrointestinal procedures. CLE can detect early-stage cancers, polyps, and other abnormalities with high precision.
Hyperspectral imaging, which captures images across a broad spectrum of light wavelengths, has made significant strides in medical diagnostics. The technology enables the differentiation of tissues based on their spectral signatures, making it useful for detecting early-stage cancers, wound assessment, and monitoring tissue oxygenation levels. Hyperspectral imaging can identify malignant tissues by analyzing subtle differences in tissue composition that are invisible to the human eye. Its non-invasive nature and high sensitivity make it a promising tool for intraoperative decision-making, helping surgeons differentiate between healthy and cancerous tissues more accurately. ...Read more
CLEVELAND, Ohio – University Hospitals has introduced a new real-time clinical decision support module with HemaLogiX ® , enhancing its long-standing transfusion analytics platform with point-of-care alerts embedded directly into the Epic electronic health record.
UH has used HemaLogiX since 2017 to support its patient blood management program, leveraging retrospective analytics and reporting to identify patterns of transfusion utilization and opportunities for improvement. Since its initial deployment in 2017, the platform has helped UH reduce transfusions by approximately 40 percent, generating over $55 million in cost savings while promoting safer, more consistent transfusion practices.
The newly released module represents a significant evolution of the platform. When a blood component is ordered in Epic, HemaLogiX now evaluates the order in real time against patient-specific data using HemaLogiX’s proprietary Transfusion Appropriateness Algorithm. If documented data do not meet set transfusion criteria, the system generates an advisory alert at the point of order entry. Clinicians retain full authority to override the alert and proceed with the transfusion, ensuring that clinical judgment remains paramount.
“This enhancement moves transfusion management from retrospective review to real-time clinical support,” said James L. Hill Jr. MD, MBA, CPE, FASA, FACHE , Chief Operating Officer, UH Parma Medical Center , and a founding clinical leader of the HemaLogiX initiative. “The alerts are designed to educate and inform at the moment decisions are made, while preserving physician autonomy.”
Traditional transfusion management tools often rely on a single threshold (e.g., hemoglobin level). HemaLogiX takes a more nuanced approach by integrating numerous patient-specific variables (e.g., vital signs, lab values and medications) across four major blood components, enabling context-aware assessments that reflect the complexity of real-world clinical decision-making.
In addition to real-time alerts, the platform continues to maintain live dashboards, updated daily to serve a variety of clinical users. Longitudinal analytics support collaborative review, education, and continuous improvement across clinical and operational teams.
“HemaLogiX has already transformed how we understand and manage transfusion practices at University Hospitals,” said Jennifer Dawson, MBA, MSN, RN , Principal Advisor, System Resource Utilization at UH. “The addition of real-time alerts adds another layer of support, reinforcing evidence-based practice at the point of care.”
Following its success at UH, the HemaLogiX platform is now commercially available through Hemaptics ® ( www.hemaptics.com ), enabling health systems nationwide to benefit from both retrospective analytics and real-time clinical decision support for transfusion management. ...Read more
Medical imaging has consistently played a crucial role in diagnostic medicine by providing essential insights into the human body. With ongoing technological advancements, new developments and trends can potentially revolutionize the industry significantly. These innovations seek to improve diagnostic accuracy, enhance patient outcomes, and optimize healthcare processes.
In the struggle to deliver great treatment at reasonable pricing, the benefits of AI in healthcare are proving to be lifesavers for true lifesavers. The benefits of AI in healthcare extend beyond diagnosis and administrative support. AI is currently pushing the boundaries by improving medication research, surgical robotics, and even mental health monitoring.
This suggests that AI is now necessary in all healthcare processes. It ensures precision, efficiency, and patient outcomes. The future of healthcare is becoming increasingly aligned with the development and integration of AI systems.
Advantages of AI in healthcare are discussed below:
Improved diagnostics and decision-making: The most noteworthy and well-known benefit of AI in healthcare is its impact on diagnostics. AI-powered imaging tools are transforming pathology and radiology. They can readily detect patterns and irregularities in medical images that the human eye might miss.
AI algorithms, for example, can detect cancerous tumors in mammograms with significantly higher accuracy and speed than traditional methods. This drastically reduces the rate of false positives and allows for prompt diagnosis.
Using AI to personalize treatment plans: AI-driven medical treatment programs incorporate multiple factors, including genetic, environmental, and lifestyle data, to guide clinical decisions. In this context, Hospital Pricing Specialists highlights how data-driven healthcare solutions contribute to improved decision-making and patient outcomes. This approach enables physicians to recommend more precise medications based on individual patient profiles, minimizing reliance on trial-and-error methods.
It can be crucial in treatments such as oncology, where the optimum chemotherapy routine can be determined based on the patient's data, significantly reducing side effects.
UX Platforms supports data-driven treatment plans by enhancing patient outcomes and improving healthcare decision-making efficiency
Enhanced drug discovery: Drug discovery is regarded as one of the most laborious and costly processes in healthcare. However, AI speeds up this process by analyzing large quantities of data and quickly identifying promising drug candidates. Machine learning algorithms can predict how different substances would react with biological systems, reducing the development cycle. This particular advantage of AI in healthcare is particularly noticeable during a public health emergency or epidemic when speedy drug discovery is crucial.
Cost reduction: The human room for mistake has always been an unavoidable component of healthcare, possibly endangering patient lives. AI has made an impact in the healthcare industry by reducing treatment errors. It features algorithms that can quickly analyze patient data, detecting anomalies and irregularities that human practitioners are likely to overlook. Doctors use AI in healthcare to eliminate human errors, maintain patient safety, and prevent malpractice claims. Furthermore, this reduces healthcare costs for doctors and patients, as well as improves the healthcare system's general efficiency. ...Read more
